Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density

Henry G. Bone, Michael R. McClung, Christian Roux, Robert R. Recker, John A. Eisman, Nadia Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Arthur C. Santora, B. Avery Ince

Research output: Contribution to journalArticlepeer-review

289 Scopus citations

Fingerprint

Dive into the research topics of 'Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density'. Together they form a unique fingerprint.

Medicine & Life Sciences